Olanzapine Concept

subject area of

• A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine  Academic Article
• A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania  Academic Article
• A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism  Academic Article
• Antipsychotic Drug Effects on Brain Morphology in First-Episode Psychosis  Conference Paper
• Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults  Academic Article
• Atypical antipsychotics and hyperglycemic emergencies: Multicentre, retrospective cohort study of administrative data  Academic Article
• Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder  Academic Article
• Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies  Academic Article
• Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007  Academic Article
• Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol  Academic Article
• Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol  Academic Article
• Does early antipsychotic response predict long-term treatment outcome?  Academic Article
• Evidence for Onset of Antipsychotic Effects Within the First 24 Hours of Treatment  Academic Article
• Falls and Fractures With Atypical Antipsychotic Medication Use  Academic Article
• Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters  Academic Article
• Lack of effect of antipsychotics on BNDF and NGF levels in hippocampus of Wistar rats  Academic Article
• Late-Onset Neuroleptic Malignant Syndrome in a Patient Using Olanzapine  Academic Article
• Olanzapine and haloperidol in first episode psychosis: Two-year data  Academic Article
• Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study  Academic Article
• Olanzapine plus fluoxetine treatment increases Nt-3 protein levels in the rat prefrontal cortex  Academic Article
• Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial  Academic Article
• Pilot Study: Access to Fitness Facility and Exercise Levels in Olanzapine-Treated Patients  Academic Article
• Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode  Academic Article
• Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders  Academic Article
• Psychotic Disorders, Eating Habits, and Physical Activity: Who Is Ready for Lifestyle Changes?  Academic Article
• The predictive value of early treatment response in antipsychotic-naive patients with first-episode psychosis: Haloperidol versus olanzapine  Academic Article
• Treatment Response to Olanzapine and Haloperidol and its Association with Dopamine D2 Receptor Occupancy in First-Episode Psychosis  Academic Article
• Treatment of self-mutilation with olanzapine.  Academic Article